12-49955360-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000486.6(AQP2):c.607-39C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.783 in 1,598,764 control chromosomes in the GnomAD database, including 495,797 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.71 ( 40090 hom., cov: 34)
Exomes 𝑓: 0.79 ( 455707 hom. )
Consequence
AQP2
NM_000486.6 intron
NM_000486.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.05
Publications
7 publications found
Genes affected
AQP2 (HGNC:634): (aquaporin 2) This gene encodes a water channel protein located in the kidney collecting tubule. It belongs to the MIP/aquaporin family, some members of which are clustered together on chromosome 12q13. Mutations in this gene have been linked to autosomal dominant and recessive forms of nephrogenic diabetes insipidus. [provided by RefSeq, Oct 2008]
AQP5-AS1 (HGNC:55474): (AQP5 and AQP2 antisense RNA 2)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-49955360-C-G is Benign according to our data. Variant chr12-49955360-C-G is described in ClinVar as Benign. ClinVar VariationId is 1180579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.807 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.710 AC: 107974AN: 152118Hom.: 40053 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
107974
AN:
152118
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.772 AC: 174849AN: 226392 AF XY: 0.769 show subpopulations
GnomAD2 exomes
AF:
AC:
174849
AN:
226392
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.791 AC: 1143716AN: 1446528Hom.: 455707 Cov.: 36 AF XY: 0.788 AC XY: 566100AN XY: 718118 show subpopulations
GnomAD4 exome
AF:
AC:
1143716
AN:
1446528
Hom.:
Cov.:
36
AF XY:
AC XY:
566100
AN XY:
718118
show subpopulations
African (AFR)
AF:
AC:
15500
AN:
32948
American (AMR)
AF:
AC:
38205
AN:
44058
Ashkenazi Jewish (ASJ)
AF:
AC:
18893
AN:
25784
East Asian (EAS)
AF:
AC:
24789
AN:
39154
South Asian (SAS)
AF:
AC:
59538
AN:
85194
European-Finnish (FIN)
AF:
AC:
43523
AN:
51478
Middle Eastern (MID)
AF:
AC:
3466
AN:
5062
European-Non Finnish (NFE)
AF:
AC:
894667
AN:
1103350
Other (OTH)
AF:
AC:
45135
AN:
59500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
13034
26068
39101
52135
65169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20688
41376
62064
82752
103440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.710 AC: 108064AN: 152236Hom.: 40090 Cov.: 34 AF XY: 0.712 AC XY: 53043AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
108064
AN:
152236
Hom.:
Cov.:
34
AF XY:
AC XY:
53043
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
20065
AN:
41534
American (AMR)
AF:
AC:
12530
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
2533
AN:
3472
East Asian (EAS)
AF:
AC:
3289
AN:
5160
South Asian (SAS)
AF:
AC:
3347
AN:
4828
European-Finnish (FIN)
AF:
AC:
8964
AN:
10622
Middle Eastern (MID)
AF:
AC:
199
AN:
292
European-Non Finnish (NFE)
AF:
AC:
54907
AN:
67998
Other (OTH)
AF:
AC:
1524
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1495
2990
4486
5981
7476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2560
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Diabetes insipidus, nephrogenic, autosomal Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.